Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
GentiBio is a biotherapeutics company developing engineered regulatory T cells programmed to treat autoimmune allergic diseases.
Dopavision is a therapeutic company developing a digital therapeutic for myopia.
Relation Therapeutics is a biotechnology company that focuses on humanizing drug discovery and development.
Octave is a precision care company that provides diagnostic tools and care solutions for neurodegenerative diseases.
Deciphex builds a network of AI empowered pathologists ensuring accessible pathology services that improves patient outcomes.
IKAS Industrial Automation is provides intelligent manufacturing solutions for IC manufacturing and packaging testing, LED, photovoltaic.
Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
Xealth is a digital health platform that enables healthcare organizations to prescribe and monitor health tools, programs, and services.
Jiamai is a new energy pneumatic component manufacturer.
Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness.
Alesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic.
Borealis Biosciences is a company in the field of next-generation RNA medicines.
LoQus23 is a DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington’s disease.
Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.
ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.
Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.
Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.
Patientory is a patient data platform that empowers individuals to control their health data and earn personalized rewards.
FundaMental Pharma is a neuroscience company with a portfolio at the preclinical stage.
Lightship is making clinical trials more accessible for patients and providers to accelerate development of better therapies for all.
Holmusk is a provider of healthcare data and technology solutions to support the treatment of mental health and chronic diseases.
Hyku is a biotech company that develops precise covalent targeting of disease-causing proteins.
Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.
Novartis has invested in 99 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Novartis's top investment sectors include Biotechnology, Health Care, Life Science, Therapeutics, Medical. The firm invests across 28 different industry categories.
Among tracked funding rounds, Aktis Oncology received $175.0M in a Series B round. Novartis's total known invested capital is $3.8B.
Novartis's average investment size is $60.5M across its portfolio of 99 companies.
Recent Novartis portfolio additions include Renovacor, GentiBio, Dopavision, Relation Therapeutics, Octave. These companies were founded in 2020 or later.